Ekso Bionics Holdings logo
Ekso Bionics Holdings EKSO
report update icon

Quarterly report 2026-Q1
added 04-28-2026

Ekso Bionics Holdings Fundamental Analysis 2026 | EKSO

Overall analysis of Ekso Bionics Holdings

Ekso Bionics Holdings (EKSO) belongs to Medical Equipment. The combined module picture suggests an overall picture without a clear positive tilt. The growth module suggests a measured expansion profile without a clear acceleration signal. The weak points are growth dynamics, so the signal needs confirmation. The bankruptcy module looks vulnerable and calls for a more cautious review. The areas holding the module back are profitability and operating risks. The business needs a stronger financial base before the p...

A sample of the full analysis can be viewed here

Overvaluation

Overvaluation based on multiples

lock

Growth vs. valuation

lock

Profitability overheating

lock

Cash flow and balance sheet strength

lock

Module summary

lock

> 80 Not overvalued
80-60 Fairly valued
60-40 Signs of overvaluation
< 40 Overvalued

The Overvaluation module evaluates whether a company’s current price may be overstated relative to its fundamentals and growth rate. It helps answer a key question:

Are overly optimistic expectations already priced into the stock?

The assessment is based on several factors that may indicate overvaluation:

  • Overvaluation based on multiples
    How expensive the company is valued by the market relative to its profit, revenue, and cash flows;

  • Growth vs. valuation
    Evaluates whether the company’s actual growth rates justify its current market valuation;

  • Profitability overheating
    Assesses whether profitability metrics are at peak levels that may be difficult to sustain;

  • Cash flow and balance sheet strength
    Shows whether the high valuation is supported by cash flows and a stable balance sheet structure.

It helps identify companies with reasonable valuations, as well as those showing signs of inflated expectations or valuations detached from fundamentals. The module is especially useful for assessing the risk of entering a position at an inflated price and determining whether the current valuation is justified by the company’s actual performance.

The Overvaluation module evaluates whether a company’s current price may be overstated relative to its fundamentals and growth rate. It helps answer a key question:

Are overly optimistic expectations already priced into the stock?

It helps identify companies with reasonable valuations, as well as those showing signs of inflated expectations or valuations detached from fundamentals. The module is especially useful for assessing the risk of entering a position at an inflated price and determining whether the current valuation is justified by the company’s actual performance.

The assessment is based on several factors that may indicate overvaluation:

  • Overvaluation based on multiples
    How expensive the company is valued by the market relative to its profit, revenue, and cash flows;

  • Growth vs. valuation
    Evaluates whether the company’s actual growth rates justify its current market valuation;

  • Profitability overheating
    Assesses whether profitability metrics are at peak levels that may be difficult to sustain;

  • Cash flow and balance sheet strength
    Shows whether the high valuation is supported by cash flows and a stable balance sheet structure.

Undervaluation

Valuation multiples

lock

Business quality

lock

Financial stability

lock

Market signals

lock

Module summary

lock

> 80 Strongly undervalued
80-60 Moderately undervalued
60-40 Neutral
< 40 Overvalued

The Undervaluation module evaluates whether a company’s current price may be below its intrinsic value. It helps answer a key question:

Does the company have upside potential because the market undervalues it?

The assessment is based on several factors reflecting fundamental attractiveness:

  • Valuation multiples
    How inexpensive the company appears relative to its own financial metrics;

  • Business quality
    Efficiency of the company’s operations and its ability to generate stable profits;

  • Financial stability
    How stable the business is and whether it can maintain current performance levels;

  • Market signals
    Compares the company’s valuation with business growth rates and investor expectations.

It helps identify companies that appear undervalued relative to their fundamentals, including businesses with strong fundamentals and reasonable valuations, as well as those whose price may have upside potential if market perception changes. This module is especially useful for finding companies where fundamentals are stronger than their current market valuation, creating potential opportunities for future price growth.

The Undervaluation module evaluates whether a company’s current price may be below its intrinsic value. It helps answer a key question:

Does the company have upside potential because the market undervalues it?

It helps identify companies that appear undervalued relative to their fundamentals, including businesses with strong fundamentals and reasonable valuations, as well as those whose price may have upside potential if market perception changes. This module is especially useful for finding companies where fundamentals are stronger than their current market valuation, creating potential opportunities for future price growth.

The assessment is based on several factors reflecting fundamental attractiveness:

  • Valuation multiples
    How inexpensive the company appears relative to its own financial metrics;

  • Business quality
    Efficiency of the company’s operations and its ability to generate stable profits;

  • Financial stability
    How stable the business is and whether it can maintain current performance levels;

  • Market signals
    Compares the company’s valuation with business growth rates and investor expectations.
A sample of the full analysis can be viewed here